Overview

Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With Hypertension

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the antihypertensive effect of azilsartan medoxomil versus placebo in Korean adults with essential hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Takeda
Treatments:
Azilsartan medoxomil